Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FSMA Supplier Verification Rule Close, But Third-Party Accreditation Stalls

This article was originally published in The Tan Sheet

Executive Summary

FDA Center for Food Safety and Applied Nutrition Director Michael Landa says rules for preventive controls for human food and the foreign supplier verification program are “in the final stages of review.” However, the rule for accreditation of third-party inspectors is stalled.

You may also be interested in...



FSMA Supplier Verification Rule Affects Finished Supplement Importers

Proposed FSMA rules would subject imported food products, including supplements, to the same safety standards as domestically produced food. The proposals are reminders that although supplement manufacturing is exempt from FSMA provisions redundant to GMP requirements, the act adds regulatory burdens for some firms.

FSMA Supplier Verification Rule Affects Finished Supplement Importers

Proposed FSMA rules would subject imported food products, including supplements, to the same safety standards as domestically produced food. The proposals are reminders that although supplement manufacturing is exempt from FSMA provisions redundant to GMP requirements, the act adds regulatory burdens for some firms.

In Brief: FSMA Rules Proposed | One-Step Exclusivity | Early At CHPA | EU Clears NovaTears

FSMA auditing, supplier verification rules proposed; Plan B One-Step gets OTC exclusivity until 2016; Early joins CHPA as VP, CFO; Novaliq’s NovaTears Gains EU approval; and Senate bill boosts NIH appropriation.

Related Content

Topics

UsernamePublicRestriction

Register

PS105717

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel